protein
ABC-type oligopeptide transporter ABCB9
Gene
ABCB9
Organism
Homo sapiens(9606)
Length
766 aa
Mass
84,475 Da
ABCB9 is an ATP-dependent oligopeptide transporter that mediates the translocation of peptides from the cytosol into the lysosomal lumen for degradation (UniProt: Q9NP78). The protein exhibits broad substrate specificity, transporting peptides ranging from 6 to at least 59 amino acids in length, with optimal activity at 23-mers. It shows preference for peptides with positively charged, aromatic, or hydrophobic residues at terminal positions.
ABCB9 is a member of the ABC transporter family and localizes to lysosomal membranes, where it participates in intracellular peptide homeostasis and protein quality control (UniProt: Q9NP78). The protein's role in lysosomal degradation pathways suggests involvement in cellular autophagy and clearance mechanisms that are fundamental to neural cell health.
In Alzheimer's disease, ABCB9 is significantly downregulated in post-mortem AD brain tissue compared to age-matched controls, with a mean log2 fold-change of −0.67 across subcellular fractions (Chaparral AD proteomics). This reduction in lysosomal peptide transport capacity may impair the clearance of proteolytic peptide products and contribute to protein aggregation pathology characteristic of AD.
Generated from the curated entity record below. May contain errors — verify against source links.
Proteomics Evidence · AD
↓ Down in ADP3
-0.671
P2
not detected
S2
not detected
S3
not detected
Mean log₂FC across detected fractions: -0.6712 (1 of 4 fractions detected)
Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.
Related Publications
Browse all →Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
Dujardin Simon et al.Nature medicine2020PMID 32572268Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.
Bai Bing et al.Neuron2020PMID 31926610A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
Seyfried Nicholas T et al.Cell systems2017PMID 27989508Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level.
Johnson Erik C B et al.Nature neuroscience2022PMID 35115731Organization and regulation of gene transcription.
Cramer PatrickNature2019PMID 31462772
Function
ATP-dependent low-affinity peptide transporter which translocates a broad spectrum of peptides from the cytosol to the lysosomal lumen for degradation (PubMed:15863492, PubMed:17977821, PubMed:18434309, PubMed:22641697, PubMed:25646430, PubMed:30353140, PubMed:30877195, PubMed:31417173). Displays a broad peptide length specificity from 6-mer up to at least 59-mer peptides with an optimum of 23-mers (PubMed:15863492, PubMed:25646430). Binds and transports smaller and larger peptides with the same affinity (PubMed:31417173). Favors positively charged, aromatic or hydrophobic residues in the N- and C-terminal positions whereas negatively charged residues as well as asparagine and methionine are not favored (PubMed:15863492, PubMed:17977821, PubMed:18434309)
Sources
Last updated 5/8/2026, 6:39:09 AM
